Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-cigarettes for Harm Reduction and Quitting in Dual Users
NCT05703672Phase 3Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by University of Kansas Medical Center. Started Jul 2023; status: recruiting.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05703672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05703672.